| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-13 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |